MOLECULERA BIOSCIENCES Trademark

Trademark Overview

On Tuesday, April 30, 2024, a trademark application was filed for MOLECULERA BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the MOLECULERA BIOSCIENCES trademark a serial number of 98526774. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, May 6, 2025. This trademark is owned by Moleculera Biosciences, Inc.. The MOLECULERA BIOSCIENCES trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Antibody testing for medical diagnostic or treatment purposes; Blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Immunochemical medical diagnostic testing services for detecting and measuring antibody levels; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical diagnostic services; Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes

Laboratory testing of materials; Medical and scientific research in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment; Medical research laboratory services; Providing a website featuring educational information in the field of clinical research; Providing information about medical research in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment; Research laboratory analysis services in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment
moleculera biosciences

General Information

Serial Number98526774
Word MarkMOLECULERA BIOSCIENCES
Filing DateTuesday, April 30, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, May 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 11, 2025

Trademark Statements

Goods and ServicesAntibody testing for medical diagnostic or treatment purposes; Blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Immunochemical medical diagnostic testing services for detecting and measuring antibody levels; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical diagnostic services; Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes
NOT AVAILABLE"BIOSCIENCES"
Goods and ServicesLaboratory testing of materials; Medical and scientific research in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment; Medical research laboratory services; Providing a website featuring educational information in the field of clinical research; Providing information about medical research in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment; Research laboratory analysis services in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 30, 2024
Primary Code042
First Use Anywhere DateThursday, February 22, 2024
First Use In Commerce DateThursday, February 22, 2024
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 30, 2024
Primary Code044
First Use Anywhere DateThursday, February 22, 2024
First Use In Commerce DateThursday, February 22, 2024

Trademark Owner History

Party NameMoleculera Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOklahoma City, OK 73104
Party NameMoleculera Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOklahoma City, OK 73104

Trademark Events

Event DateEvent Description
Tuesday, April 30, 2024NEW APPLICATION ENTERED
Wednesday, October 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 16, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, October 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 14, 2024ASSIGNED TO EXAMINER
Tuesday, November 19, 2024NON-FINAL ACTION E-MAILED
Tuesday, November 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 19, 2024NON-FINAL ACTION WRITTEN
Monday, February 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 17, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 17, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 18, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 5, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 11, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 11, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 6, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

biosciences moleculera medical services testing treatment diagnostic disorders purposes analysis laboratories provided